Company Announcements

The Wistar Institute and Rockland Immunochemicals announced in July a partnership for discovery and research, including value-added collaborative opportunities to advance work across the translational gap.

Axiogenesis, a provider of tissue-specific human cell types, signed a sublicense agreement with GE Healthcare to use human IPSCs, enabling it to develop cellular assays and models for use in drug discovery and toxicity screening.

Cytox and Affymetrix entered into a strategic partnership to develop and commercialize a blood-based genetic assay for research in diagnosis and prognosis of Alzheimer’s disease and Mild Cognitive Impairment. Cytox will use Affymetrix’s Axiom genotyping platform.

SYGNIS licensed its Double Switch technology to Thermo Fisher Scientific to develop, market and sell products and services for the detection and analysis of protein interactions in vivo.

Mologic signed a supply licensing agreement with Innova Biosciences for Innova’s Lightning-Link and InnovaCoat GOLD technologies.

InSphero named PerkinElmer as the exclusive distributor of its InSphero 3D culture technology, consisting of the GravityPLUS Hanging Drop System and GravityTRAP Ultra-Low Attachment Plates.

Seahorse Bioscience Labware changed its name to Seahorse Microplates in August.

Product Introductions

Neogen launched in July an ELISA screening test for synthetic cathinones or “bath salts.”

In August, Neogen released the Igenity-Elite dairy genomic test that analyzes nearly 150,000 gene markers.

In July, Molecular Devices introduced six EarlyTox cell viability assay kits, a new family of fluorescence-based reagents optimized for microplate readers.

Thermo Fisher Scientific released the PrioCHECK Trichinella AAD for testing swine carcasses for Trichinella.

Diagenode introduced the Premium Reduced Representation Bisulfite Sequencing Kit and the Premium Whole Genome Bisulfite Sequencing Kit.

Ahlstrom launched the GenCollect and GenCollect Color specimen collection cards for forensics and genomics.

GE Healthcare Dharmacon introduced over one million CRISPR-Cas9 gene editing products that use a new algorithm to design reagents. The products include predesigned synthetic CRISPR RNAs, single guide RNA (sgRNA) lentiviral particles and pooled sgRNA lentiviral particle libraries.

Corning Life Sciences introduced single-use, cryopreserved Corning HepatoCells, an alternative to primary human hepatocytes for ADME/Tox research. Only a single medium is required for the culturing and assay process.